Cargando…
Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease
Obesity and non-alcoholic fatty liver disease (NAFLD) are on the rise world-wide; despite fervent advocacy for healthier diets and enhanced physical activity, these disorders persist unabated and, long-term, are major causes of morbidity and mortality. Numerous fundamental biochemical and molecular...
Autores principales: | Arivazhagan, Lakshmi, López-Díez, Raquel, Shekhtman, Alexander, Ramasamy, Ravichandran, Schmidt, Ann Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263181/ https://www.ncbi.nlm.nih.gov/pubmed/35811725 http://dx.doi.org/10.3389/fcvm.2022.937071 |
Ejemplares similares
-
Advanced lipoxidation end products (ALEs) as RAGE binders: Mass spectrometric and computational studies to explain the reasons why
por: Mol, Marco, et al.
Publicado: (2018) -
Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases
por: Moldogazieva, Nurbubu T., et al.
Publicado: (2019) -
Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models
por: Egaña-Gorroño, Lander, et al.
Publicado: (2020) -
Inflammation Meets Metabolism: Roles for the Receptor for Advanced Glycation End Products Axis in Cardiovascular Disease
por: Senatus, Laura, et al.
Publicado: (2021) -
Lipoxidation and cancer immunity
por: Martín-Sierra, C., et al.
Publicado: (2019)